RT Journal Article
SR Electronic
T1 An age-structured epidemiological model of the Belgian COVID-19 epidemic
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.23.20077115
DO 10.1101/2020.04.23.20077115
A1 Deforche, Koen
YR 2020
UL http://medrxiv.org/content/early/2020/04/29/2020.04.23.20077115.abstract
AB COVID-19 has prompted many countries to implement extensive social distancing to stop the rapid spread of the virus, in order to prevent over-loading health care systems. Yet, the main epidemic parameters of this virus are not well understood. In the absence of broad testing or serological surveillance, it is hard to evaluate or predict the impact of different strategies to exit implemented lock-down measures. An age-structured epidemiological model was developed, which distinguishes between the younger versus older population (e.g. < 65 and ≥ 65). Because the illness severity is markedly different for these two populations, such a separation is necessary when estimating the model based on death and hospitalization incidence data. The model was applied to data of the Belgian epidemic and used to predict how the epidemic would react to a relaxing of social distancing measures.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was received.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data has been made openly available by the Belgian governement (Sciensano). https://github.com/kdeforche/epi-mcmc